Compounds > tacrolimus

tacrolimus and Multiple-Sclerosis--Relapsing-Remitting

tacrolimus has been researched along with Multiple-Sclerosis--Relapsing-Remitting* in 2 studies

Other Studies

2 other study(ies) available for tacrolimus and Multiple-Sclerosis--Relapsing-Remitting

ArticleYear
Fulminant Hepatitis Associated With Echovirus 25 During Treatment With Ocrelizumab for Multiple Sclerosis.
    JAMA neurology, 2019, 07-01, Volume: 76, Issue:7

    Topics: Adult; Antibodies, Monoclonal, Humanized; Basiliximab; Echovirus Infections; Female; Graft Rejection; Humans; Immunocompromised Host; Immunologic Factors; Immunosuppressive Agents; Liver Transplantation; Massive Hepatic Necrosis; Multiple Sclerosis, Relapsing-Remitting; Tacrolimus

2019
Improvement of multiple sclerosis on tacrolimus plus mycophenolate mofetil after liver transplantation. Clinical improvement of multiple sclerosis in a patient requiring liver transplantation for acute liver failure following interferon-beta therapy.
    Transplant international : official journal of the European Society for Organ Transplantation, 2007, Volume: 20, Issue:12

    Topics: Female; Humans; Immunosuppressive Agents; Interferon-beta; Liver Failure; Liver Transplantation; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Mycophenolic Acid; Tacrolimus

2007